Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

David Fink

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Procedures

Devices

Gene Transfer Techniques

Anatomy

Physiology

Disorders

Pain

Genes & Molecular Sequences

Transgenes

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
85
Mata, Marina
77
Glorioso, Joseph
24
Goins, William
20
Wolfe, Darren
15
Krisky, David
14
Oligino, Thomas
13
Hao, Shuanglin
11
Marconi, Pierfrancesco
10
Huang, Shaohua
10
Goss, James
10
Chattopadhyay, Munmun
8
DeLuca, Neal
8
Poliani, PL
5
Goss, James
5
Burton, Edward

Sign-in to see all Coauthors

Publications

TOP 3
Zhou Zhigang; Peng Xiangmin; Insolera Ryan; Fink David J; Mata Marina
IL-10 promotes neuronal survival following spinal cord injury.
Zhou Zhigang; Peng Xiangmin; Insolera Ryan; Fink David J; Mata Marina
Interleukin-10 provides direct trophic support to neurons.
Zhou Zhigang; Peng Xiangmin; Fink David J; Mata Marina
HSV-mediated transfer of artemin overcomes myelin inhibition to improve outcome after spinal cord injury.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of David Fink (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Zhou Zhigang; Peng Xiangmin; Insolera Ryan; Fink David J; Mata Marina
IL-10 promotes neuronal survival following spinal cord injury.
Experimental neurology 2009;220(1):183-90.
2009: Zhou Zhigang; Peng Xiangmin; Insolera Ryan; Fink David J; Mata Marina
Interleukin-10 provides direct trophic support to neurons.
Journal of neurochemistry 2009;110(5):1617-27.
2009: Zhou Zhigang; Peng Xiangmin; Fink David J; Mata Marina
HSV-mediated transfer of artemin overcomes myelin inhibition to improve outcome after spinal cord injury.
Molecular therapy : the journal of the American Society of Gene Therapy 2009;17(7):1173-9.
2009: Fink David J; Albin Roger L
What sort of change to believe in: an alternate opinion.
Annals of neurology 2009;65(5):619.
2009: Chattopadhyay Munmun; Walter Claire; Mata Marina; Fink David J
Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons.
Brain : a journal of neurology 2009;132(Pt 4):879-88.
2009: Glorioso Joseph C; Fink David J
Herpes vector-mediated gene transfer in the treatment of chronic pain.
Molecular therapy : the journal of the American Society of Gene Therapy 2009;17(1):13-8.
2008: Mata Marina; Chattopadhyay Munmun; Fink David J
Gene therapy for the treatment of diabetic neuropathy.
Current diabetes reports 2008;8(6):431-6.
2008: Fink David J; Mata Marina
HSV gene transfer in the treatment of chronic pain.
Sheng li xue bao : [Acta physiologica Sinica] 2008;60(5):610-6.
2008: Srinivasan Rahul; Fink David J; Glorioso Joseph C
HSV vectors for gene therapy of chronic pain.
Current opinion in molecular therapeutics 2008;10(5):449-55.
2008: Chattopadhyay Munmun; Mata Marina; Fink David J
Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(26):6652-8.
2008: Mata Marina; Hao Shuanglin; Fink David J
Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha.
Neuroscience letters 2008;437(3):209-13.
2008: Mata Marina; Hao Shuanglin; Fink David J
Applications of gene therapy to the treatment of chronic pain.
Current gene therapy 2008;8(1):42-8.
2008: Zhou Z; Peng X; Hao S; Fink D J; Mata M
HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia.
Gene therapy 2008;15(3):183-90.
2007: Wolfe Darren; Hao Shuanglin; Hu Jian; Srinivasan Rahul; Goss James; Mata Marina; Fink David J; Glorioso Joseph C
Engineering an endomorphin-2 gene for use in neuropathic pain therapy.
Pain 2007;133(1-3):29-38.
2007: Chattopadhyay M; Mata M; Goss J; Wolfe D; Huang S; Glorioso J C; Fink D J
Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer.
Diabetologia 2007;50(7):1550-8.
2007: Hao S; Mata M; Glorioso J C; Fink D J
Gene transfer to interfere with TNFalpha signaling in neuropathic pain.
Gene therapy 2007;14(13):1010-6.
2007: Mata Marina; Fink David J
Gene therapy for pain.
Anesthesiology 2007;106(6):1079-80.
2007: Hao Shuanglin; Mata Marina; Fink David J
Viral vector-based gene transfer for treatment of chronic pain.
International anesthesiology clinics 2007;45(2):59-71.
2006: Puskovic Veljko; Wolfe Darren; Wechuck James; Krisky David; Collins Jeff; Glorioso Joseph C; Fink David J; Mata Marina
HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;14(5):710-5.
2006: Lee John Y K; Fink David J; Mata Marina
Vector-mediated gene transfer to express inhibitory neurotransmitters in dorsal root ganglion reduces pain in a rodent model of lumbar radiculopathy.
Spine 2006;31(14):1555-8.
2006: Peng Xiang-min; Zhou Zhi-gang; Glorioso Joseph C; Fink David J; Mata Marina
Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury.
Annals of neurology 2006;59(5):843-51.
2006: Mata Marina; Chattopadhyay Munmun; Fink David J
Gene therapy for the treatment of sensory neuropathy.
Expert opinion on biological therapy 2006;6(5):499-507.
2006: Liu Jun; Tai Changfeng; de Groat William C; Peng Xiang-min; Mata Marina; Fink David J
Release of GABA from sensory neurons transduced with a GAD67-expressing vector occurs by non-vesicular mechanisms.
Brain research 2006;1073-1074():297-304.
2006: Hao Shuanglin; Mata Marina; Glorioso Joseph C; Fink David J
HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain.
Molecular pain 2006;2():6.
2005: Chattopadhyay M; Krisky D; Wolfe D; Glorioso J C; Mata M; Fink D J
HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy.
Gene therapy 2005;12(18):1377-84.
2005: Burton Edward A; Fink David J; Glorioso Joseph C
Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications.
Current opinion in molecular therapeutics 2005;7(4):326-36.
2005: Chattopadhyay Munmun; Wolfe Darren; Mata Marina; Huang Shaohua; Glorioso Joseph C; Fink David J
Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;12(2):307-13.
2005: Hao Shuanglin; Mata Marina; Wolfe Darren; Huang Shaohua; Glorioso Joseph C; Fink David J
Gene transfer of glutamic acid decarboxylase reduces neuropathic pain.
Annals of neurology 2005;57(6):914-8.
2005: Chen Xiao-Ping; Mata Marina; Fink David J
Use of laser capture microdissection together with in situ hybridization and real-time PCR to study distribution of latent herpes simplex virus genomes in mouse trigeminal ganglia.
Methods in molecular biology (Clifton, N.J.) 2005;293():285-93.
2004: Hu Jian; Mata Marina; Hao Shuanglin; Zhang Gui; Fink David J
Central sprouting of uninjured small fiber afferents in the adult rat spinal cord following spinal nerve ligation.
The European journal of neuroscience 2004;20(7):1705-12.
2004: Puskovic Veljko; Wolfe Darren; Goss James; Huang Shaohua; Mata Marina; Glorioso Joseph C; Fink David J
Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(1):67-75.
2004: Liu Jun; Wolfe Darren; Hao Shuanglin; Huang Shaohua; Glorioso Joseph C; Mata Marina; Fink David J
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;10(1):57-66.
2004: Chattopadhyay Munmun; Goss James; Wolfe Darren; Goins William C; Huang Shaohua; Glorioso Joseph C; Mata Marina; Fink David J
Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy.
Brain : a journal of neurology 2004;127(Pt 4):929-39.
2004: Mata Marina; Glorioso Joseph C; Fink David J
Gene therapy: novel treatments for polyneuropathy and chronic pain.
Current neurology and neuroscience reports 2004;4(1):1-2.
2004: Glorioso Joseph C; Fink David J
Herpes vector-mediated gene transfer in treatment of diseases of the nervous system.
Annual review of microbiology 2004;58():253-71.
2004: Wolfe Darren; Wechuck James B; Krisky David M; Goff Julie P; Goins William F; Ozuer Ali; Epperly Michael E; Greenberger Joel S; Fink David J; Glorioso Joseph C
Delivery of herpes simplex virus-based vectors to stem cells.
Methods in molecular biology (Clifton, N.J.) 2004;246():339-52.
2004: Goss James R; Natsume Atsushi; Wolfe Darren; Mata Marina; Glorioso Joseph C; Fink David J
Delivery of herpes simplex virus-based vectors to the nervous system.
Methods in molecular biology (Clifton, N.J.) 2004;246():309-22.
2004: Goins William F; Wolfe Darren; Krisky David M; Bai Qing; Burton Ed A; Fink David J; Glorioso Joseph C
Delivery using herpes simplex virus: an overview.
Methods in molecular biology (Clifton, N.J.) 2004;246():257-99.
2003: Natsume Atsushi; Wolfe Darren; Hu Jian; Huang Shaohua; Puskovic Veljko; Glorioso Joseph C; Fink David J; Mata Marina
Enhanced functional recovery after proximal nerve root injury by vector-mediated gene transfer.
Experimental neurology 2003;184(2):878-86.
2003: Mata Marina; Glorioso Joseph C; Fink David J
Gene transfer to the nervous system: prospects for novel treatments directed at diseases of the aging nervous system.
The journals of gerontology. Series A, Biological sciences and medical sciences 2003;58(12):M1111-8.
2003: Glorioso Joseph C; Mata Marina; Fink David J
Exploiting the neurotherapeutic potential of peptides: targeted delivery using HSV vectors.
Expert opinion on biological therapy 2003;3(8):1233-9.
2003: Mata Marina; Glorioso Joseph; Fink David J
Development of HSV-mediated gene transfer for the treatment of chronic pain.
Experimental neurology 2003;184 Suppl 1():S25-9.
2003: Fink David J; Glorioso Joseph; Mata Marina
Therapeutic gene transfer with herpes-based vectors: studies in Parkinson's disease and motor nerve regeneration.
Experimental neurology 2003;184 Suppl 1():S19-24.
2003: Glorioso Joseph C; Mata Marina; Fink David J
Gene therapy for chronic pain.
Current opinion in molecular therapeutics 2003;5(5):483-8.
2003: Hao Shuanglin; Mata Marina; Wolfe Darren; Huang Shaohua; Glorioso Joseph C; Fink David J
HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain.
Molecular therapy : the journal of the American Society of Gene Therapy 2003;8(3):367-75.
2003: Burton E A; Glorioso J C; Fink D J
Gene therapy progress and prospects: Parkinson's disease.
Gene therapy 2003;10(20):1721-7.
2003: Fink David; Mata Marina; Glorioso Joseph C
Cell and gene therapy in the treatment of pain.
Advanced drug delivery reviews 2003;55(8):1055-64.
2003: Glorioso Joseph C; Mata Marina; Fink David J
Therapeutic gene transfer to the nervous system using viral vectors.
Journal of neurovirology 2003;9(2):165-72.
2003: Hao Shuanglin; Mamiya Keiko; Takahata Osamu; Iwasaki Hiroshi; Mata Marina; Fink David J
Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats.
Anesthesia and analgesia 2003;96(4):1065-71, table of contents.
2003: Hao Shuanglin; Mata Marina; Goins William; Glorioso Joseph C; Fink David J
Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain.
Pain 2003;102(1-2):135-42.
2003: Chattopadhyay Munmun; Goss James; Lacomis David; Goins William C; Glorioso Joseph C; Mata Marina; Fink David J
Protective effect of HSV-mediated gene transfer of nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animals.
The European journal of neuroscience 2003;17(4):732-40.
2002: Burton Edward A; Fink David J; Glorioso Joseph C
Gene delivery using herpes simplex virus vectors.
DNA and cell biology 2002;21(12):915-36.
2002: Mata Marina; Glorioso Joseph C; Fink David J
Targeted gene delivery to the nervous system using herpes simplex virus vectors.
Physiology & behavior 2002;77(4-5):483-8.
2002: Goss James R; Harley Cara F; Mata Marina; O'Malley Mark E; Goins William F; Hu XiaoPing; Glorioso Joseph C; Fink David J
Herpes vector-mediated expression of proenkephalin reduces bone cancer pain.
Annals of neurology 2002;52(5):662-5.
2002: Hu Jian; Fink David; Mata Marina
Microarray analysis suggests the involvement of proteasomes, lysosomes, and matrix metalloproteinases in the response of motor neurons to root avulsion.
The European journal of neuroscience 2002;16(8):1409-16.
2002: Goins William F; Marconi Peggy; Krisky David; Wolfe Darren; Glorioso Joseph C; Ramakrishnan Ramesh; Fink David J
Construction of replication-defective herpes simplex virus vectors.
Current protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.] 2002;Chapter 12():Unit 12.11.
2002: Goss James R; Goins William F; Lacomis David; Mata Marina; Glorioso Joseph C; Fink David J
Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse.
Diabetes 2002;51(7):2227-32.
2002: Chen Xiao-Ping; Mata Marina; Kelley Mary; Glorioso Joseph C; Fink David J
The relationship of herpes simplex virus latency associated transcript expression to genome copy number: a quantitative study using laser capture microdissection.
Journal of neurovirology 2002;8(3):204-10.
2002: Glorioso Joseph C; Fink David J
Use of HSV vectors to modify the nervous system.
Current opinion in drug discovery & development 2002;5(2):289-95.
2002: Natsume Atsushi; Mata Marina; Wolfe Darren; Oligino Thomas; Goss James; Huang Shaohua; Glorioso Joseph; Fink David J
Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect.
Journal of neurotrauma 2002;19(1):61-8.
2002: Chattopadhyay Munmun; Wolfe Darren; Huang Shaohua; Goss James; Glorioso Joseph C; Mata Marina; Fink David J
In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3.
Annals of neurology 2002;51(1):19-27.
2002: Goins William F; Krisky David M; Wolfe Darren P; Fink David J; Glorioso Joseph C
Development of replication-defective herpes simplex virus vectors.
Methods in molecular medicine 2002;69():481-507.
2001: Mata M; Zhang M; Hu X; Fink D J
HveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons, of the rat peripheral nervous system.
Journal of neurovirology 2001;7(5):476-80.
2001: Natsume A; Mata M; Goss J; Huang S; Wolfe D; Oligino T; Glorioso J; Fink D J
Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration.
Experimental neurology 2001;169(2):231-8.
2001: Goss J R; Mata M; Goins W F; Wu H H; Glorioso J C; Fink D J
Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion.
Gene therapy 2001;8(7):551-6.
2001: Yamada M; Natsume A; Mata M; Oligino T; Goss J; Glorioso J; Fink D J
Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion.
Experimental neurology 2001;168(2):225-30.
2001: Burton E A; Wechuck J B; Wendell S K; Goins W F; Fink D J; Glorioso J C
Multiple applications for replication-defective herpes simplex virus vectors.
Stem cells (Dayton, Ohio) 2001;19(5):358-77.
2000: Chen X p; Li J; Mata M; Goss J; Wolfe D; Glorioso J C; Fink D J
Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture.
Journal of virology 2000;74(21):10132-41.
2000: Fink D J
Gene therapy for Canavan disease?
Annals of neurology 2000;48(1):9-10.
2000: Liu T; Khanna K M; Chen X; Fink D J; Hendricks R L
CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons.
The Journal of experimental medicine 2000;191(9):1459-66.
2000: Fink D J; DeLuca N A; Yamada M; Wolfe D P; Glorioso J C
Design and application of HSV vectors for neuroprotection.
Gene therapy 2000;7(2):115-9.
1999: Wolfe D; Goins W F; Yamada M; Moriuchi S; Krisky D M; Oligino T J; Marconi P C; Fink D J; Glorioso J C
Engineering herpes simplex virus vectors for CNS applications.
Experimental neurology 1999;159(1):34-46.
1999: Yamada M; Oligino T; Mata M; Goss J R; Glorioso J C; Fink D J
Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(7):4078-83.
1999: Goins W F; Lee K A; Cavalcoli J D; O'Malley M E; DeKosky S T; Fink D J; Glorioso J C
Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity.
Journal of virology 1999;73(1):519-32.
1998: Krisky D M; Wolfe D; Goins W F; Marconi P C; Ramakrishnan R; Mata M; Rouse R J; Fink D J; Glorioso J C
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons.
Gene therapy 1998;5(12):1593-603.
1998: Moriuchi S; Oligino T; Krisky D; Marconi P; Fink D; Cohen J; Glorioso J C
Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
Cancer research 1998;58(24):5731-7.
1998: Krisky D M; Marconi P C; Oligino T J; Rouse R J; Fink D J; Cohen J B; Watkins S C; Glorioso J C
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications.
Gene therapy 1998;5(11):1517-30.
1998: Oligino T; Poliani P L; Wang Y; Tsai S Y; O'Malley B W; Fink D J; Glorioso J C
Drug inducible transgene expression in brain using a herpes simplex virus vector.
Gene therapy 1998;5(4):491-6.
1997: Krisky D M; Marconi P C; Oligino T; Rouse R J; Fink D J; Glorioso J C
Rapid method for construction of recombinant HSV gene transfer vectors.
Gene therapy 1997;4(10):1120-5.
1997: Swarnkar A; Fukui M B; Fink D J; Rao G R
MR imaging of brachial plexopathy in neurolymphomatosis.
AJR. American journal of roentgenology 1997;169(4):1189-90.
1997: Rasty S; Poliani P L; Fink D J; Glorioso J C
Deletion of the S component inverted repeat sequence c' and the nonessential genes U(S)1 through U(S)5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system.
Journal of neurovirology 1997;3(4):247-64.
1997: Goins W F; Krisky D; Marconi P; Oligino T; Ramakrishnan R; Poliani P L; Fink D J; Glorioso J C
Herpes simplex virus vectors for gene transfer to the nervous system.
Journal of neurovirology 1997;3 Suppl 1():S80-8.
1997: Fink D J; Poliani P L; Oligino T; Krisky D M; Goins W F; Glorioso J C
Development of an HSV-based vector for the treatment of Parkinson's disease.
Experimental neurology 1997;144(1):103-21.
1997: Fink D J; Glorioso J C
Engineering herpes simplex virus vectors for gene transfer to neurons.
Nature medicine 1997;3(3):357-9.
1997: Mata M; Honegger P; Fink D J
Modulation of phosphorylation of neuronal cytoskeletal proteins by neuronal depolarization.
Cellular and molecular neurobiology 1997;17(1):129-40.
1997: Glorioso J C; Goins W F; Schmidt M C; Oligino T; Krisky D M; Marconi P C; Cavalcoli J D; Ramakrishnan R; Poliani P L; Fink D J
Engineering herpes simplex virus vectors for human gene therapy.
Advances in pharmacology (San Diego, Calif.) 1997;40():103-36.
1997: Fink D J; Glorioso J C
Herpes simplex virus-based vectors: problems and some solutions.
Advances in neurology 1997;72():149-56.
1996: Oligino T; Poliani P L; Marconi P; Bender M A; Schmidt M C; Fink D J; Glorioso J C
In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16.
Gene therapy 1996;3(10):892-9.
1996: Marconi P; Krisky D; Oligino T; Poliani P L; Ramakrishnan R; Goins W F; Fink D J; Glorioso J C
Replication-defective herpes simplex virus vectors for gene transfer in vivo.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11319-20.
1996: Makarova O; Gorneva G; Wu F; Farutin V; Villeponteau B; Poliani L; Fink D; Levine M
Incorporation of nuclear matrix attachment regions into the herpes simplex virus type 1 genome does not induce long-term expression of a foreign gene during latency.
Gene therapy 1996;3(9):829-33.
1996: Ramakrishnan R; Poliani P L; Levine M; Glorioso J C; Fink D J
Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR.
Journal of virology 1996;70(9):6519-23.
1996: Soares K; Hwang D Y; Ramakrishnan R; Schmidt M C; Fink D J; Glorioso J C
cis-acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency-associated promoter 1 (LAP1) in vitro and in vivo.
Journal of virology 1996;70(8):5384-94.
1996: Fink D; Knapp P E; Mata M
Differential expression of Na,K-ATPase isoforms in oligodendrocytes and astrocytes.
Developmental neuroscience 1996;18(4):319-26.
1996: Fink D J; DeLuca N A; Goins W F; Glorioso J C
Gene transfer to neurons using herpes simplex virus-based vectors.
Annual review of neuroscience 1996;19():265-87.
1995: Glorioso J C; Bender M A; Goins W F; Fink D J; DeLuca N
HSV as a gene transfer vector for the nervous system.
Molecular biotechnology 1995;4(1):87-99.
1995: Fink D J; Fang D; Li T; Mata M
Na,K-ATPase beta subunit isoform expression in the peripheral nervous system of the rat.
Neuroscience letters 1995;183(3):206-9.
1995: Glorioso J; Bender M A; Fink D; DeLuca N
Herpes simplex virus vectors.
Molecular and cell biology of human diseases series 1995;5():33-63.
1995: Fink D J; Ramakrishnan R; Marconi P; Goins W F; Holland T C; Glorioso J C
Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.
Clinical neuroscience (New York, N.Y.) 1995;3(5):284-91.
1995: Glorioso J C; DeLuca N A; Fink D J
Development and application of herpes simplex virus vectors for human gene therapy.
Annual review of microbiology 1995;49():675-710.
1994: Ramakrishnan R; Levine M; Fink D J
PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant.
Journal of virology 1994;68(11):7083-91.
1994: Fink D J; Datta S; Mata M
Isoform specific reductions in Na+,K(+)-ATPase catalytic (alpha) subunits in the nerve of rats with streptozotocin-induced diabetes.
Journal of neurochemistry 1994;63(5):1782-6.
1994: Goins W F; Sternberg L R; Croen K D; Krause P R; Hendricks R L; Fink D J; Straus S E; Levine M; Glorioso J C
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.
Journal of virology 1994;68(4):2239-52.
1994: Ramakrishnan R; Fink D J; Jiang G; Desai P; Glorioso J C; Levine M
Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain.
Journal of virology 1994;68(3):1864-73.
1994: Jin C F; Mata M; Fink D J
Rapid construction of deleted DNA fragments for use as internal standards in competitive PCR.
PCR methods and applications 1994;3(4):252-5.
1994: Glorioso J C; Goins W F; DeLuca N; Fink D J
Development of herpes simplex virus as a gene transfer vector for the nervous system.
Gene therapy 1994;1 Suppl 1():S39.
1994: Glorioso J C; Goins W F; Meaney C A; Fink D J; DeLuca N A
Gene transfer to brain using herpes simplex virus vectors.
Annals of neurology 1994;35 Suppl():S28-34.
1994: Glorioso J C; Goins W F; Fink D J; DeLuca N A
Herpes simplex virus vectors and gene transfer to brain.
Developments in biological standardization 1994;82():79-87.
1993: Mata M; Datta S; Jin C F; Fink D J
Differential axonal transport of individual Na,K-ATPase catalytic (alpha) subunit isoforms in rat sciatic nerve.
Brain research 1993;618(2):295-8.
1993: Mata M; Jin C F; Fink D J
Axotomy increases CNTF receptor mRNA in rat spinal cord.
Brain research 1993;610(1):162-5.
1992: Mata M; Hieber V; Beaty M; Clevenger M; Fink D J
Activity-dependent regulation of Na+, K(+)-ATPase alpha isoform mRNA expression in vivo.
Journal of neurochemistry 1992;59(2):622-6.
1992: Mata M; Kupina N; Fink D J
Phosphorylation-dependent neurofilament epitopes are reduced at the node of Ranvier.
Journal of neurocytology 1992;21(3):199-210.
1992: Fink D J; Sternberg L R; Weber P C; Mata M; Goins W F; Glorioso J C
In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer.
Human gene therapy 1992;3(1):11-9.
1991: Mata M; Kupina N; Fink D J
Calpain II in rat peripheral nerve.
Brain research 1991;564(2):328-31.
1991: Mata M; Fink D J; Ernst S A; Siegel G J
Immunocytochemical demonstration of Na+,K(+)-ATPase in internodal axolemma of myelinated fibers of rat sciatic and optic nerves.
Journal of neurochemistry 1991;57(1):184-92.
1991: Hieber V; Siegel G J; Fink D J; Beaty M W; Mata M
Differential distribution of (Na, K)-ATPase alpha isoforms in the central nervous system.
Cellular and molecular neurobiology 1991;11(2):253-62.
1991: Mata M; Siegel G J; Hieber V; Beaty M W; Fink D J
Differential distribution of (Na,K)-ATPase alpha isoform mRNAs in the peripheral nervous system.
Brain research 1991;546(1):47-54.
1990: Mata M; Alessi D; Fink D J
S100 is preferentially distributed in myelin-forming Schwann cells.
Journal of neurocytology 1990;19(3):432-42.
1989: Mata M; Fink D J
Ca++-ATPase in the central nervous system: an EM cytochemical study.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1989;37(7):971-80.
1988: Mata M; Fink D J
Calmodulin distribution in peripheral nerve: an EM immunocytochemical study.
Brain research 1988;475(2):297-304.
1988: Mata M; Kahn S N; Fink D J
A direct electron microscopic immunocytochemical study of IgM paraproteinemic neuropathy.
Archives of neurology 1988;45(6):693-7.
1988: Mata M; Staple J; Fink D J
Distribution of albumin-like immunoreactivity in rat sciatic nerve after nerve crush injury.
Journal of neuropathology and experimental neurology 1988;47(3):271-81.
1988: Mata M; Staple J; Fink D J
Cytochemical localization of Ca2+-ATPase activity in peripheral nerve.
Brain research 1988;445(1):47-54.
1987: Mata M; Staple J; Fink D J
The distribution of serum albumin in rat peripheral nerve.
Journal of neuropathology and experimental neurology 1987;46(4):485-94.
1987: Fink D J; Purkiss D; Mata M
Retrograde axonal transport in rat sciatic nerve after nerve crush injury.
Brain research bulletin 1987;19(1):29-33.
1987: Mata M; Staple J; Fink D J
Ultrastructural distribution of Ca++ within neurons. An oxalate pyroantimonate study.
Histochemistry 1987;87(4):339-49.
1986: Fink D J; Purkiss D; Mata M
beta,beta'-Iminodipropionitrile impairs retrograde axonal transport.
Journal of neurochemistry 1986;47(4):1032-8.
1986: Mata M; Staple J; Fink D J
Changes in intra-axonal calcium distribution following nerve crush.
Journal of neurobiology 1986;17(5):449-67.
1986: Fink D J; Purkiss D; Mata M
A quantitative study of retrograde axonal transport in motor and sensory neurons.
Brain research bulletin 1986;16(4):537-40.
1985: Mata M; Staple J; Fink D J
Ultrastructural localization of slow retrograde axonal transport: an autoradiographic study.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1985;5(11):2900-8.
1985: Fink D J; Purkiss D; Mata M
Rapid retrograde transport of proteins in sensory neurons in rats.
Brain research 1985;345(2):394-7.
1982: Gainer H; Fink D J
Evidence for slow retrograde transport of serum albumin in rat sciatic nerve.
Brain research 1982;233(2):404-8.
1981: Fink D J; Russell J T; Gainer H; Brownstein M J; Baumgold J
Multiple-rate components of axonally transported proteins in the hypothalamo-neurohypophysial system of the rat.
Journal of neurobiology 1981;12(5):487-503.
1980: Fink D J; Gainer H
Axonal transport of proteins. A new view using in vivo covalent labeling.
The Journal of cell biology 1980;85(2):175-86.
1980: Fink D J; Gainer H
Retrograde axonal transport of endogenous proteins in sciatic nerve demonstrated by covalent labeling in vivo.
Science (New York, N.Y.) 1980;208(4441):303-5.
1980: Mata M; Fink D J; Gainer H; Smith C B; Davidsen L; Savaki H; Schwartz W J; Sokoloff L
Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity.
Journal of neurochemistry 1980;34(1):213-5.
1979: Fink D J; Gainer H
The use of a labeled acylating probe for the study of fast axonal transport, in vivo.
Brain research 1979;177(1):208-13.
1979: Schwartz W J; Smith C B; Davidsen L; Savaki H; Sokoloff L; Mata M; Fink D J; Gainer H
Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat.
Science (New York, N.Y.) 1979;205(4407):723-5.
1977: Fink D J; Morest D K
Formation of synaptic endings by colossal fibers in the vestibular epithelium of the chick embryo.
Neuroscience 1977;2(2):229-52.
1972: Goldstein D; Fink D; Mettee D R
Cognition of arousal and actual arousal as determinants of emotion.
Journal of personality and social psychology 1972;21(1):41-51.

Sign-in to see more